1. Guariguata L, Whiting D, Hambleton I, Beagley J, Linnenkamp U, Shaw J. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Research and Clinical Practice 2014; 103(2): 137-49.## [DOI:10.1016/j.diabres.2013.11.002] [PMID]

2. Zimmet P, Alberti KG, Magliano DJ, Bennett PH. Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nature Reviews Endocrinology 2016; 12(10): 616-22. ## [DOI:10.1038/nrendo.2016.105] [PMID]

3. Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Noshad S, et al. Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005-2011. Diabetes Research and Clinical Practice 2014; 103(2): 319-27. ## [DOI:10.1016/j.diabres.2013.12.034] [PMID]

4. Cheng YJ, Imperatore G, Geiss LS, Wang J, Saydah SH, Cowie CC, et al. Secular changes in the age-specific prevalence of diabetes among US adults: 1988-2010. Diabetes Care 2013; 36(9): 2690-6. ## [DOI:10.2337/dc12-2074] [PMID] []

5. Soriguer F, Goday A, Bosch-Comas A, Bordiú E, Calle-Pascual A, Carmena R, et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@ bet. es Study. Diabetologia 2012; 55(1): 88-93. ## [DOI:10.1007/s00125-011-2336-9] [PMID] []

6. Kirpichnikov D, Sowers JR. Diabetes mellitus and diabetes-associated vascular disease. Trends in Endocrinology & Metabolism 2001; 12(5): 225-30. ## [DOI:10.1016/S1043-2760(01)00391-5] [PMID]

7. Avogaro A, de Kreutzenberg SV, Negut C, Tiengo A, Scognamiglio R. Diabetic cardiomyopathy: a metabolic perspective. The American Journal of Cardiology 2004; 93(8): 13-6. ## [DOI:10.1016/j.amjcard.2003.11.003] [PMID]

8. Goldstein BJ. Insulin resistance as the core defect in type 2 diabetes mellitus. The American Journal of Cardiology 2002; 90(5): 3-10. ## [DOI:10.1016/S0002-9149(02)02553-5] [PMID]

9. Akram M. Diabetes Mellitus Type II: Treatment strategies and options: A review. J Diabetes Metab 2013; 4(304): 2. ## [DOI:10.4172/2155-6156.1000304]

10. Sumbul S, Ahmad MA, Asif M, Akhtar M. Myrtus communis Linn.-A review. Indian J Nat Prod Resour 2011; 2(4): 395-402. ##

11. Nyunai N, Njikam N, Mounier C, Pastoureau P. Blood glucose lowering effect of aqueous leaf extracts of Ageratum conyzoides in rats. African Journal of Traditional, Complementary and Alternative Medicines 2006; 3(3): 76-9. ## [DOI:10.4314/ajtcam.v3i3.31168]

12. Misra H, Soni M, Silawat N, Mehta D, Mehta B, Jain D. Antidiabetic activity of medium-polar extract from the leaves of Stevia rebaudiana Bert.(Bertoni) on alloxan-induced diabetic rats. Journal of Pharmacy and Bioallied Sciences 2011; 3(2): 242. ## [DOI:10.4103/0975-7406.80779] [PMID] []

13. Dias MI, Barros L, Dueñas M, Pereira E, Carvalho AM, Alves RC, et al. Chemical composition of wild and commercial Achillea millefolium L. and bioactivity of the methanolic extract, infusion and decoction. Food Cemistry 2013; 141(4): 4152-60. ## [DOI:10.1016/j.foodchem.2013.07.018] [PMID]

14. Applequist WL, Moerman DE. Yarrow (Achillea millefolium L.): A Neglected Panacea? A Review of Ethnobotany, Bioactivity, and Biomedical Research1. Economic Botany 2011; 65(2): 209. ## [DOI:10.1007/s12231-011-9154-3]

15. Yazdanparast R, Ardestani A, Jamshidi S. Experimental diabetes treated with Achillea santolina: effect on pancreatic oxidative parameters. Journal of Ethnopharmacology 2007; 112(1): 13-8. ## [DOI:10.1016/j.jep.2007.01.030] [PMID]

16. Mustafa KG, Ganai BA, Akbar S, Dar MY, Masood A. β-Cell protective efficacy, hypoglycemic and hypolipidemic effects of extracts of Achillea millifolium in diabetic rats. Chinese Journal of Natural Medicines 2012; 10(3): 185-9. ## [DOI:10.3724/SP.J.1009.2012.00185]

17. Bonnefont-Rousselot D, Bastard J, Jaudon M, Delattre J. Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes and Metabolism 2000; 26(3): 163-77. ##

18. Anwar MM, Meki A-RM. Oxidative stress in streptozotocin-induced diabetic rats: effects of garlic oil and melatonin. Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology 2003; 135(4): 539-47. ## [DOI:10.1016/S1095-6433(03)00114-4] [PMID]

19. Chetan J, Pradeep Kumar P, Prakash H. Antidiabetic and antihypertensive potential of selected asteraceae plant species. American Journal of Advanced Drug Delivery 2014; 2(3): 355-63. ##

20. Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiological Reviews 2013; 93(1): 137-88. ## [DOI:10.1152/physrev.00045.2011] [PMID]

21. Davey GC, Patil SB, O'Loughlin A, O'Brien T. Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus. Frontiers in Endocrinology 2014; 5: 86. ## [DOI:10.3389/fendo.2014.00086] [PMID] []

22. Lakshmi T, Geetha R, Roy A, Kumar SA. Yarrow (Achillea millefolium linn). A herbal medicinal plant with broad therapeutic use-A review. Int J Pharm Sci Rev Res 2011; 9(2): 136-41. ##

23. Nekoei N, Shams Ardakani M, Emami A. Treatment of diseases by plants. 1st ed. Tehran: Rah Kamal Publications; 2002; 253-5. ##

24. Khoori V, Nayebpour S, Ashrafian Y, Naseri M. Effects of the Methanol extract of achillea santolina on the electrophysiological characteristics of isolated atrioventricular node of male rat. Journal of Gorgan University of Medical Sciences 1999; 1(3): 5-15. ##

25. Ogawa A, Johnson JH, Ohneda M, McAllister CT, Inman L, Alam T, et al. Roles of insulin resistance and beta-cell dysfunction in dexamethasone-induced diabetes. Journal of Clinical Investigation 1992; 90(2): 497. ## [DOI:10.1172/JCI115886] [PMID] []

26. Chen Y, Jungsuwadee P, Vore M, Butterfield DA, St Clair DK. Collateral damage in cancer chemotherapy: oxidative stress in nontargeted tissues. Molecular Interventions 2007; 7(3): 147. ## [DOI:10.1124/mi.7.3.6] [PMID]

27. Shpilberg Y, Beaudry JL, D'Souza A, Campbell JE, Peckett A, Riddell MC. A rodent model of rapid-onset diabetes induced by glucocorticoids and high-fat feeding. Disease Models & Mechanisms 2012; 5(5): 671-80. ## [DOI:10.1242/dmm.008912] [PMID] []

28. Martínez BB, Pereira ACC, Muzetti JH, Telles FDP, Mundim FGL, Teixeira MA. Experimental model of glucocorticoid-induced insulin resistance. Acta Cirurgica Bbrasileira 2016; 31(10): 645-9. ## [DOI:10.1590/S0102-865020160100000001] [PMID]

29. Yang Sl, Zhu Ly, Han R, Sun Ll, Li Jx, Dou Jt. Pathophysiology of peripheral arterial disease in diabetes mellitus. Journal of Diabetes 2017; 9(2): 133-40. ## [DOI:10.1111/1753-0407.12474] [PMID]

30. Hazra A, Pyszczynski NA, DuBois DC, Almon RR, Jusko WJ. Modeling of corticosteroid effects on hepatic low-density lipoprotein receptors and plasma lipid dynamics in rats. Pharmaceutical Research 2008; 25(4): 769-80. ## [DOI:10.1007/s11095-007-9371-8] [PMID] []

31. Sekiya M, Yahagi N, Tamura Y, Okazaki H, Igarashi M, Ohta K, et al. Hormone-sensitive lipase deficiency suppresses insulin secretion from pancreatic islets of Lepob/ob mice. Biochemical and Biophysical Research Communications 2009; 387(3): 511-5. ## [DOI:10.1016/j.bbrc.2009.07.078] [PMID]

32. Szkudelski T, Szkudelska K. Anti‐diabetic effects of resveratrol. Annals of the New York Academy of Sciences 2011; 1215(1): 34-9. ## [DOI:10.1111/j.1749-6632.2010.05844.x] [PMID]

33. Tsutsumi K. Lipoprotein lipase and atherosclerosis. Current Vascular Ppharmacology 2003; 1(1): 11-7. ## [DOI:10.2174/1570161033386673] [PMID]

34. Asgary S, Naderi G, Sarrafzadegan N, Mohammadifard N, Mostafavi S, Vakili R. Antihypertensive and antihyperlipidemic effects of Achillea wilhelmsii. Drugs Under Experimental and Clinical Research 2000; 26(3): 89-94. ##

35. Ahmadvand H, Tavafi M, Shahsavari G, Khosrobeigi A, Bagheri S, Abdolahpour F. Hypolipidemic and antiatherogenic effects of Satureja khozestanica essential oil in alloxan-induced type 1 diabetic rats. Zahedan Journal of Research in Medical Sciences 2013; 15(8): 26-9. ## [DOI:10.1186/s40200-014-0119-9] [PMID] []

36. Rosenfeldt F, Wilson M, Lee G, Kure C, Ou R, Braun L, et al. Oxidative stress in surgery in an ageing population: pathophysiology and therapy. Experimental Gerontology 2013; 48(1): 45-54. ## [DOI:10.1016/j.exger.2012.03.010] [PMID]

37. Tozyo T, Yoshimura Y, Sakurai K, Uchida N, Takeda Y, Nakai H, et al. Novel antitumor sesquiterpenoids in Achillea millefolium. Chemical and Pharmaceutical Bulletin 1994; 42(5): 1096-100. ## [DOI:10.1248/cpb.42.1096] [PMID]